Swift Biosciences

Swift Biosciences

Swift Biosciences is a biotechnology company founded in 2010 by Timothy Harkins.

Swift provides research tools for long term improvements in the health of individuals and their communities all around the world, specifically in the fight against cancer and understanding the complexities of inherited diseases.

Timeline

July 2017
Swift Biosciences raises a $12,200,000 series D round from Arboretum Ventures.
October 17, 2013
Swift Biosciences raises a $7,000,000 series B round from Mercury Fund.
August 19, 2010
Swift Biosciences raises a $3,000,000 series A round from Mercury Fund.

Funding rounds

Funding round
Funding type
Funding round amount (USD)
Funding round date
Investment
Swift Biosciences Series A round
3,000,000
August 19, 2010
3 Results
Results per page:
Page 1 of 1

People

Name
Role
LinkedIn

Mahmoud Shaaban

Employee

Mel Hernandez

Employee

Walt Young

Investor

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
Swift Biosciences
March 4, 2021
www.prnewswire.com:443
/PRNewswire/ -- Swift Biosciences, pioneers in the development of DNA and RNA library preparation kits for Next-Generation Sequencing (NGS) and SPT Labtech,...
Swift Biosciences
February 18, 2021
www.prnewswire.com:443
/PRNewswire/ -- Genemarkers LLC, leaders in genomic research from Kalamazoo, MI and Swift Biosciences, pioneers in the development of DNA and RNA library...
Swift Biosciences
February 4, 2021
www.prnewswire.com:443
/PRNewswire/ -- A pioneer in the development of DNA and RNA library preparation kits for Next-Generation Sequencing (NGS) systems Swift Biosciences announces...
Swift Biosciences
January 27, 2021
www.prnewswire.com:443
/PRNewswire/ -- Swift Biosciences of Ann Arbor, MI has released a targeted gene panel that covers 100% of the SARS-CoV-2 S gene, even with limited viral titers....

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.